PSG.DE

PharmaSGP Holding SE [PSG.DE] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PSG.DE Stock Summary

Top 10 Correlated ETFs

PSG.DE

Top 10 Correlated Stocks

PSG.DE

In the News

PSG.DE Financial details

Company Rating
-
Market Cap
268.58M
Income
14.99M
Revenue
97.55M
Book val./share
-
Cash/share
-
Dividend
0.49
Dividend %
2.18%
Employees
79
Optionable
No
Shortable
Yes
Earnings
16 Apr 2024
P/E
17.99
Forward P/E
-
PEG
4.33
P/S
2.77
P/B
7.37
P/C
-
P/FCF
10.62
Quick Ratio
2.05
Current Ratio
2.56
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.26
EPS next Y
-
EPS next Q
-
EPS this Y
12.36%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
1.04%
EPS Q/Q
17.65%
-
-
-
-
SMA20
1.82%
SMA50
19.16%
SMA100
5.44%
Inst Own
-
Inst Trans
-
ROA
11%
ROE
45%
ROC
0.22%
Gross Margin
91%
Oper. Margin
25%
Profit Margin
15%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
17.7-29.5
52W High
-2.07%
52W Low
+67.06%
RSI
53.79
Rel Volume
0.88
Avg Volume
457
Volume
400
Perf Week
-0.7%
Perf Month
4.41%
Perf Quarter
12.7%
Perf Half Y
7.58%
-
-
-
-
Beta
0.06
-
-
Volatility
0.21%, 0.5%
Prev Close
-0.7%
Price
28.4
Change
1.43%

PSG.DE Financial Performance

PSG.DE Dividend History

PSG.DE Frequently Asked Questions

What is PharmaSGP Holding SE stock symbol ?

PharmaSGP Holding SE is a DE stock and trading under the symbol PSG.DE

What is PharmaSGP Holding SE stock quote today ?

PharmaSGP Holding SE stock price is $28.4 today.

Is PharmaSGP Holding SE stock public?

Yes, PharmaSGP Holding SE is a publicly traded company.

Something similar

Top by Market Cap
VTSAX
VOO
BRYN.DE
AMZN
DHR-PB
Top Correlated ETFs
SDIP.L
HYGN.L
PADV.L
ISFE.L
HDGB.L
Top Correlated Stocks
MANAPPURAM.NS
PCIP.L
7605.T
AREIT.PA
MOUR.BR
Similar Market Cap
TAALA.HE
AFP.SW
PREC.PA
SFIX
CZFS

Company Profile

Healthcare Drug Manufacturers - Specialty & Generic
  • Volume Average 457
  • Market Capitalization 268.58M
  • Employee 79
  • CEO Ms. Natalie Weigand
  • Headquarters Gräfelfing,DE
  • IPO Date 2020-06-19
  • Website https://pharmasgp.com

PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.